Sale!

MATR3 Gene Amyotrophic lateral sclerosis type 21 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MATR3 Gene Amyotrophic Lateral Sclerosis Type 21 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the MATR3 gene, which are associated with the development of Amyotrophic Lateral Sclerosis (ALS) type 21. ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.

The test is particularly crucial for individuals with a family history of ALS or symptoms indicative of the disease, as identifying the genetic mutation can help in understanding the risk, potential progression, and possible familial implications of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, the test ensures accuracy and confidentiality in handling patient samples.

The cost of the MATR3 Gene Amyotrophic Lateral Sclerosis Type 21 Genetic Test is 4400 AED. This investment covers the genetic analysis and the expertise required to interpret the results accurately. Given the complexity and the specialized nature of the test, the cost reflects the comprehensive analysis and detailed report provided to the patient, which can be instrumental in planning for treatment and management of the condition.

It’s important for patients considering this test to consult with a healthcare provider or a genetic counselor to fully understand the implications of the results and to ensure that it is the right step in their diagnostic journey.

Description

MATR3 Gene Amyotrophic lateral sclerosis type 21 Genetic Test

Components: MATR3 Gene Amyotrophic lateral sclerosis type 21 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MATR3 Gene Amyotrophic lateral sclerosis type 21 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MATR3 Gene Amyotrophic lateral sclerosis type 21.

Test Details:

The MATR3 gene is a gene that provides instructions for making a protein called matrin-3. Mutations in this gene have been associated with an increased risk for developing a type of motor neuron disease called amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive neurological disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness and wasting.

NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once to identify potential disease-causing mutations. An NGS test for ALS may include analysis of the MATR3 gene, along with other genes known to be associated with the disease.

Testing for mutations in the MATR3 gene may be recommended for individuals with a family history of ALS or for those experiencing symptoms of the disease. Early detection of genetic mutations can allow for earlier intervention and potentially better outcomes. However, it’s important to note that not all individuals with mutations in the MATR3 gene will develop ALS, and not all cases of ALS are caused by mutations in this gene.

Test Name	MATR3 Gene Amyotrophic lateral sclerosis type 21 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for MATR3 Gene Amyotrophic lateral sclerosis type 21 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MATR3 Gene Amyotrophic lateral sclerosis type 21
Test Details	The MATR3 gene is a gene that provides instructions for making a protein called matrin-3. Mutations in this gene have been associated with an increased risk for developing a type of motor neuron disease called amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. ALS is a progressive neurological disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness and wasting. NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once to identify potential disease-causing mutations. An NGS test for ALS may include analysis of the MATR3 gene, along with other genes known to be associated with the disease. Testing for mutations in the MATR3 gene may be recommended for individuals with a family history of ALS or for those experiencing symptoms of the disease. Early detection of genetic mutations can allow for earlier intervention and potentially better outcomes. However, it’s important to note that not all individuals with mutations in the MATR3 gene will develop ALS, and not all cases of ALS are caused by mutations in this gene.